All Posts by

Matthew Splett

Research Snapshot: Researchers identify genes that predict pediatric AML outcomes

UF Health researchers have used a promising approach by integrating CRISPR/cas9-based drug screening with patients’ clinical outcome to identify genes and pathways that predict how patients will respond to the standard firstline chemotherapy treatment regimen used to treat patients with acute myeloid leukemia, or AML.

Purpose Beyond a Cure: Advancing Hodgkin Lymphoma Treatment

Emilie Lynch, '18, has passed the 5-year milestone that doctors consider a yardstick for being cured of Hodgkin lymphoma not once but three times. Today, she channels her experience into a career as a clinical pharmacy specialist at UF Health.